Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Fish and Richardson
Queensland Health
Cipla
McKinsey
Citi
UBS
Colorcon
Dow
Medtronic

Generated: October 18, 2017

DrugPatentWatch Database Preview

Nadolol - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for nadolol and what is the scope of nadolol freedom to operate?

Nadolol
is the generic ingredient in two branded drugs marketed by Sandoz, Lupin Ltd, Ivax Sub Teva Pharms, Amneal Pharms Co, Invagen Pharms, Zydus Pharms Usa Inc, Us Worldmeds Llc, Teva Pharms, Mylan, and Orion Corp Orion, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for nadolol. Twenty suppliers are listed for this compound.

Summary for Generic Name: nadolol

US Patents:0
Tradenames:2
Applicants:10
NDAs:11
Drug Master File Entries: see list5
Suppliers / Packagers: see list20
Bulk Api Vendors: see list28
Clinical Trials: see list21
Patent Applications: see list5,266
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:nadolol at DailyMed

Pharmacology for Ingredient: nadolol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms Co
NADOLOL
nadolol
TABLET;ORAL208832-002Jun 2, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Ivax Sub Teva Pharms
NADOLOL
nadolol
TABLET;ORAL074229-002Aug 30, 1996ABRXNoNo► Subscribe► Subscribe► Subscribe
Orion Corp Orion
NADOLOL
nadolol
TABLET;ORAL201893-001Sep 16, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Ivax Sub Teva Pharms
NADOLOL
nadolol
TABLET;ORAL074255-001Jan 24, 1996ABRXNoNo► Subscribe► Subscribe► Subscribe
Ivax Sub Teva Pharms
NADOLOL
nadolol
TABLET;ORAL074255-003Jan 24, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa Inc
NADOLOL
nadolol
TABLET;ORAL207761-003Jul 28, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms
NADOLOL
nadolol
TABLET;ORAL074368-001Aug 31, 1994DISCNNoNo► Subscribe► Subscribe► Subscribe
Sandoz
NADOLOL
nadolol
TABLET;ORAL074501-002Nov 9, 1995ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa Inc
NADOLOL
nadolol
TABLET;ORAL207761-002Jul 28, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Us Worldmeds Llc
CORGARD
nadolol
TABLET;ORAL018063-001Approved Prior to Jan 1, 1982ABRXYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: nadolol

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Us Worldmeds Llc
CORGARD
nadolol
TABLET;ORAL018063-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Us Worldmeds Llc
CORGARD
nadolol
TABLET;ORAL018063-005Oct 28, 1986► Subscribe► Subscribe
Us Worldmeds Llc
CORGARD
nadolol
TABLET;ORAL018063-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Us Worldmeds Llc
CORGARD
nadolol
TABLET;ORAL018063-004Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Us Worldmeds Llc
CORGARD
nadolol
TABLET;ORAL018063-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Us Worldmeds Llc
CORGARD
nadolol
TABLET;ORAL018063-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Us Worldmeds Llc
CORGARD
nadolol
TABLET;ORAL018063-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Us Worldmeds Llc
CORGARD
nadolol
TABLET;ORAL018063-005Oct 28, 1986► Subscribe► Subscribe
Us Worldmeds Llc
CORGARD
nadolol
TABLET;ORAL018063-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Us Worldmeds Llc
CORGARD
nadolol
TABLET;ORAL018063-004Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Boehringer Ingelheim
Baxter
Moodys
US Department of Justice
Queensland Health
Cerilliant
Julphar
Mallinckrodt
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot